The Immunomodulator Market: Decoding Interferon Beta Drugs Market Interferon beta drugs are a cornerstone in the treatment of multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system. These drugs, which include interferon beta-1a, interferon beta-1b, and peginterferon beta-1a, work by modulating the immune system to reduce the frequency and severity of MS relapses and slow disease progression. As the global prevalence of MS...
0 Shares
134 Views
0 Reviews